Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition

J Lipid Res. 2011 Dec;52(12):2262-2271. doi: 10.1194/jlr.M018283. Epub 2011 Sep 21.

Abstract

Lipid transfer inhibitor protein (LTIP) exists in both active and inactive forms. Incubation (37°C) of plasma causes LTIP to transfer from a 470 kDa inactive complex to LDL where it is active. Here, we investigate the mechanisms underlying this movement. Inhibiting LCAT or cholesteryl ester transfer protein (CETP) reduced incubation-induced LTIP translocation by 40-50%. Blocking both LCAT and CETP completely prevented LTIP movement. Under appropriate conditions, either factor alone could drive maximum LTIP transfer to LDL. These data suggest that chemical modification of LDL, the 470 kDa complex, or both facilitate LTIP movement. To test this, LDL and the 470 kDa fraction were separately premodified by CETP and/or LCAT activity. Modification of the 470 kDa fraction had no effect on subsequent LTIP movement to native LDL. Premodification of LDL, however, induced spontaneous LTIP movement from the native 470 kDa particle to LDL. This transfer depended on the extent of LDL modification and correlated negatively with changes in the LDL phospholipid + cholesterol-to-cholesteryl ester + triglyceride ratio. We conclude that LTIP translocation is dependent on LDL lipid composition, not on its release from the inactive complex. Compositional changes that reduce the surface-to-core lipid ratio of LDL promote LTIP binding and activation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Apolipoproteins / metabolism*
  • Cholesterol Ester Transfer Proteins / metabolism
  • Humans
  • Lipoproteins, LDL / chemistry*
  • Lipoproteins, LDL / metabolism*
  • Molecular Weight
  • Phosphatidylcholine-Sterol O-Acyltransferase / metabolism
  • Protein Transport

Substances

  • Apolipoproteins
  • CETP protein, human
  • Cholesterol Ester Transfer Proteins
  • Lipoproteins, LDL
  • apolipoprotein F
  • Phosphatidylcholine-Sterol O-Acyltransferase